A Walsh

6.7k citations

32 papers · 5.9k · 2 hit papers · h-index 29

Impact in

Surgery top 0.5%
- Cholesterol and Lipid Metabolism
- Lipoproteins and Cardiovascular Health
Cardiology and Cardiovascular Medicine top 2%
- Lipid metabolism and disorders

Papers in

Surgery 25
- Cholesterol and Lipid Metabolism 25
- Lipoproteins and Cardiovascular Health 1
Cardiology and Cardiovascular Medicine 7
- Lipid metabolism and disorders 7

Co-authors: Jan L. Breslow (26 shared papers)Tony Hayek (11 shared papers)Katriina Aalto‐Setälä (3 shared papers)Edward A. Rubin (2 shared papers)Jonathan D. Smith (3 shared papers)Andrew S. Plump (3 shared papers)Judy G. Verstuyft (1 shared paper)Alan R. Tall (13 shared papers)
Journals: Journal of Clinical Investigation (13 papers)Journal of Biological Chemistry (9 papers)Journal of Lipid Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)Carcinogenesis (1 paper)
Partner nations: United States Israel Austria

In The Last Decade

A Walsh

32 papers receiving 5.7k citations

A Walsh's Hit Papers

align trajectories log scale

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells 1992 · 1.9k citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

1992 Cell
1990 Science

Peers

Countries citing papers authored by A Walsh

Since Specialization

Citations

This map shows the geographic impact of A Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Walsh more than expected).

Fields of papers citing papers by A Walsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Walsh. The network helps show where A Walsh may publish in the future.

Co-authors

The 25 scholars most cited alongside A Walsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A Walsh Line = papers co-authored together A Walsh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells Cell ·Andrew S. Plump, Jonathan D. Smith, Tony Hayek, Katriina Aalto‐Setälä, A Walsh, Judy G. Verstuyft, Edward A. Rubin, Jan L. Breslow Hit paper breakdown →	1992	1944
2	Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice Science ·Yasushi Ito, Neal Azrolan, Anita M. O'Connell, A Walsh, Jan L. Breslow Hit paper breakdown →	1990	484
3	In vivo protection against endotoxin by plasma high density lipoprotein. Proceedings of the National Academy of Sciences ·Daniel M. Levine, T S Parker, Thomas M. Donnelly, A Walsh, Albert L. Rubin	1993	421
4	Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. Journal of Clinical Investigation ·Katriina Aalto‐Setälä, Edward A A Fisher, X Chen, Tova Chajek‐Shaul, Tony Hayek, Rudolf Zechner, A Walsh, Rajasekhar Ramakrishnan	1992	415
5	Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice Journal of Biological Chemistry ·Luis B. Agellon, A Walsh, Tony Hayek, Philippe Moulin, Xian‐Cheng Jiang, S.A. Shelanski, Jan L. Breslow, Alan R. Tall	1991	268
6	Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. Journal of Clinical Investigation ·Tony Hayek, Lori Masucci-Magoulas, Xian Li Jiang, A Walsh, Edward A. Rubin, Jan L. Breslow, Alan R. Tall	1995	238
7	High Levels of Human Apolipoprotein A-I in Transgenic Mice Result in Increased Plasma Levels of Small High Density Lipoprotein (HDL) Particles Comparable to Human HDL3 Journal of Biological Chemistry ·A Walsh, Yasushi Ito, Jan L. Breslow	1989	216
8	Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. Journal of Clinical Investigation ·Xian‐Cheng Jiang, Luis B. Agellon, A Walsh, Jan L. Breslow, Alan R. Tall	1992	197
9	Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. Journal of Clinical Investigation ·Sanja Levak‐Frank, H. Radner, A Walsh, Rudolf Stollberger, Gabriele Knipping, Gerald Höefler, Wolfgang Sattler, Peter H. Weinstock	1995	197
10	Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. Journal of Clinical Investigation ·Xian Li Jiang, Omar Luis Francone, Can Bruce, Ross W. Milne, A Walsh, Jan L. Breslow, Alan R. Tall +1 other	1996	163
11	Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice. Journal of Clinical Investigation ·Tony Hayek, Yasushi Ito, Neal Azrolan, Roy B. Verdery, K Aalto-Setälä, A Walsh, Jan L. Breslow	1993	131
12	Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. Journal of Clinical Investigation ·Neil S. Shachter, Tony Hayek, Todd Leff, Jonathan D. Smith, Daniel W. Rosenberg, A Walsh, Rajasekhar Ramakrishnan, Ira J. Goldberg	1994	121
13	Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. Journal of Clinical Investigation ·Tony Hayek, Neal Azrolan, Roy B. Verdery, A Walsh, Tova Chajek‐Shaul, Luis B. Agellon, Alan R. Tall, Jan L. Breslow	1993	120
14	An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels. Journal of Clinical Investigation ·Tony Hayek, Tova Chajek‐Shaul, A Walsh, Luis B. Agellon, Philippe Moulin, Alan R. Tall, Jan L. Breslow	1992	110
15	Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles. Journal of Biological Chemistry ·Xian‐Cheng Jiang, Lori Masucci-Magoulas, Jefferson Mar, Menghan Lin, A Walsh, Jan L. Breslow, Alan R. Tall	1993	90
16	Intestinal expression of the human apoA-I gene in transgenic mice is controlled by a DNA region 3' to the gene in the promoter of the adjacent convergently transcribed apoC-III gene. Journal of Lipid Research ·A Walsh, Neal Azrolan, Ke Wang, A Marcigliano, Anita M. O'Connell, Jan L. Breslow	1993	86
17	Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. Journal of Clinical Investigation ·Lori Masucci-Magoulas, Philippe Moulin, Xian‐Cheng Jiang, A Walsh, Jan L. Breslow, Alan R. Tall +1 other	1995	75
18	Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. Journal of Clinical Investigation ·Katriina Aalto‐Setälä, C L Bisgaier, Karen A. Kieft, Maret G. Traber, H J Kayden, Rajasekhar Ramakrishnan, A Walsh, Arnold D. Essenburg	1994	73
19	Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters. Proceedings of the National Academy of Sciences ·Tova Chajek‐Shaul, Tony Hayek, A Walsh, Jan L. Breslow	1991	68
20	Dietary Cholesterol Fails to Stimulate the Human Cholesterol 7α-Hydroxylase Gene (CYP7A1) in Transgenic Mice Journal of Biological Chemistry ·Luis B. Agellon, Victor A. B. Drover, Sukhinder Kaur Cheema, Franck G. Gbaguidi, A Walsh	2002	68

About A Walsh

A Walsh is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Immunology, Molecular Biology and Cancer Research, having authored 32 papers that have together received 5.9k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (25 papers), Lipid metabolism and disorders (7 papers), Genomics and Chromatin Dynamics (2 papers), Epigenetics and DNA Methylation (1 paper), Sepsis Diagnosis and Treatment (1 paper), Atherosclerosis and Cardiovascular Diseases (1 paper), Animal Genetics and Reproduction (1 paper) and Lipoproteins and Cardiovascular Health (1 paper). The work is most often cited by research in Surgery (2.9k citations), Cardiology and Cardiovascular Medicine (1.5k citations), Immunology (1k citations), Clinical Biochemistry (155 citations) and Biochemistry (89 citations). A Walsh has collaborated with scholars based in United States, Israel and Austria. Frequent co-authors include Jan L. Breslow, Tony Hayek, Katriina Aalto‐Setälä, Edward A. Rubin, Jonathan D. Smith, Andrew S. Plump, Judy G. Verstuyft, Alan R. Tall, Neal Azrolan and Luis B. Agellon. Their work appears in journals such as Journal of Clinical Investigation, Journal of Biological Chemistry, Journal of Lipid Research, Proceedings of the National Academy of Sciences and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

A Walsh

Impact in

Papers in i

In The Last Decade

A Walsh

A Walsh's Hit Papers

Peers

Countries citing papers authored by A Walsh

Fields of papers citing papers by A Walsh

All Works

About A Walsh

Explore authors with similar magnitude of impact

Papers in